ATRX and gastric cancer: In this study, through comparing somatic mutation profiles derived from male and female GC patients, we identified for the first time that the ATRX mutation preferentially occurred in female GC patients was associated with higher TMB, increased anticancer immunity and favorable clinical benefit to ICI.